In the News

Northland Properties president, Tom Gaglardi, announces $3 million gift to JDRF Canada

Canadian business executive, Tom Gaglardi, President of Northland Properties Corporation and owner of the Dallas Stars, presented a generous $3M gift to JDRF Canada to support type 1 diabetes research in the areas of encapsulation, and beta cell replacement and regeneration.  


Government of Canada and JDRF join forces to defeat diabetes

Building a strong partnership to accelerate type 1 diabetes clinical trials research


JDRF & Lilly Canada fund UBC research that could allow people with type 1 diabetes to produce their own insulin

JDRF and Lilly Canada have awarded a post-doctoral fellowship grant of CAN$60,000 to promising researcher Dr. Cara Ellis, a post-doctoral fellow from the University of British Columbia (UBC).


The 2016 JDRF DIA-BEAT-IT Gala exceeds its goal!

$550,000 raised to accelerate funding for type 1 diabetes research


JDRF and the University of Toronto support research into a skin patch to prevent common, life-threatening risk of T1D

TORONTO – October 20, 2016, JDRF and the University of Toronto are pleased to announce a $400,000 (USD) research grant to support the development of a skin [transdermal] patch to prevent hypoglycemia – a common, potentially life-threatening, risk for people living with type 1 diabetes ...


JDRF funds U of T Engineering research to improve cell transplantation to treat type 1 diabetes

JDRF and the University of Toronto are supporting research that will help improve islet transplantation and make the procedure more widely available for patients living with type 1 diabetes (T1D).


JDRF and McGill University work to optimize performance of artificial pancreas systems

JDRF Canada awards $466,450 (USD) to Dr. Ahmad Haidar and his team at McGill University to improve the artificial pancreas system




JDRF and UBC work to eliminate the burden for those living with type 1 diabetes

JDRF Canada awards new research grant to Dr. Kieffer to explore new options for stem cell derived transplants for diabetes patients 


Lets turn type one into type none